83 related articles for article (PubMed ID: 25626535)
1. Microchip ELISA coupled with cell phone to detect ovarian cancer HE4 biomarker in urine.
Wang S; Akbas R; Demirci U
Methods Mol Biol; 2015; 1256():111-21. PubMed ID: 25626535
[TBL] [Abstract][Full Text] [Related]
2. Integration of cell phone imaging with microchip ELISA to detect ovarian cancer HE4 biomarker in urine at the point-of-care.
Wang S; Zhao X; Khimji I; Akbas R; Qiu W; Edwards D; Cramer DW; Ye B; Demirci U
Lab Chip; 2011 Oct; 11(20):3411-8. PubMed ID: 21881677
[TBL] [Abstract][Full Text] [Related]
3. [HE4--a new tumor marker for ovarian cancer].
Manolov V; Marinov B; Vasilev V; Andreeva A
Akush Ginekol (Sofiia); 2011; 50 Suppl 2():11-5. PubMed ID: 22524132
[TBL] [Abstract][Full Text] [Related]
4. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
5. LC-MS/MS analysis of ovarian cancer metastasis-related proteins using a nude mouse model: 14-3-3 zeta as a candidate biomarker.
He Y; Wu X; Liu X; Yan G; Xu C
J Proteome Res; 2010 Dec; 9(12):6180-90. PubMed ID: 21028892
[TBL] [Abstract][Full Text] [Related]
6. HE4-test of urine and body fluids for diagnosis of gynecologic cancer.
Qu W; Gao Q; Chen H; Tang Z; Zhu X; Jiang SW
Expert Rev Mol Diagn; 2017 Mar; 17(3):239-244. PubMed ID: 28117603
[TBL] [Abstract][Full Text] [Related]
7. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine.
Ye B; Skates S; Mok SC; Horick NK; Rosenberg HF; Vitonis A; Edwards D; Sluss P; Han WK; Berkowitz RS; Cramer DW
Clin Cancer Res; 2006 Jan; 12(2):432-41. PubMed ID: 16428483
[TBL] [Abstract][Full Text] [Related]
8. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.
Moore RG; Brown AK; Miller MC; Skates S; Allard WJ; Verch T; Steinhoff M; Messerlian G; DiSilvestro P; Granai CO; Bast RC
Gynecol Oncol; 2008 Feb; 108(2):402-8. PubMed ID: 18061248
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic value of combining detection of human epididymis protein 4 and CA125 in patients with malignant ovarian carcinoma].
Wang MJ; Qi J; Wang H; Li XX; Wei BJ; Fu C; Gao J; Han BB
Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):540-3. PubMed ID: 22093635
[TBL] [Abstract][Full Text] [Related]
10. Detection and monitoring of ovarian cancer.
Su Z; Graybill WS; Zhu Y
Clin Chim Acta; 2013 Jan; 415():341-5. PubMed ID: 23165217
[TBL] [Abstract][Full Text] [Related]
11. Direct ELISA.
Lin AV
Methods Mol Biol; 2015; 1318():61-7. PubMed ID: 26160564
[TBL] [Abstract][Full Text] [Related]
12. HE4 in ovarian cancer: from discovery to clinical application.
Montagnana M; Danese E; Giudici S; Franchi M; Guidi GC; Plebani M; Lippi G
Adv Clin Chem; 2011; 55():1-20. PubMed ID: 22126021
[TBL] [Abstract][Full Text] [Related]
13. Combined detection of sialic acid and hydroxyproline in diagnosis of ovarian cancer and its comparison with human epididymis protein 4 and carbohydrate antigen 125.
Li PL; Zhang X; Li TF; Wang LL; Du LT; Yang YM; Li J; Wang HY; Zhang Y; Wang CX
Clin Chim Acta; 2015 Jan; 439():148-53. PubMed ID: 25445414
[TBL] [Abstract][Full Text] [Related]
14. [HE4 and CA125 in ovarian cancer].
Manolov V; Marinov B; Vasilev V
Akush Ginekol (Sofiia); 2012; 51(2):21-8. PubMed ID: 23234010
[TBL] [Abstract][Full Text] [Related]
15. Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms.
Hellstrom I; Heagerty PJ; Swisher EM; Liu P; Jaffar J; Agnew K; Hellstrom KE
Cancer Lett; 2010 Oct; 296(1):43-8. PubMed ID: 20381233
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence.
Havrilesky LJ; Whitehead CM; Rubatt JM; Cheek RL; Groelke J; He Q; Malinowski DP; Fischer TJ; Berchuck A
Gynecol Oncol; 2008 Sep; 110(3):374-82. PubMed ID: 18584856
[TBL] [Abstract][Full Text] [Related]
17. Discovery and application of protein biomarkers for ovarian cancer.
Gagnon A; Ye B
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):9-13. PubMed ID: 18196999
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of HE4 as an extrabiomarker to CA125 to improve detection of ovarian carcinoma: is it time for a step forward?
Azzam AZ; Hashad DI; Kamel NA
Arch Gynecol Obstet; 2013 Jul; 288(1):167-72. PubMed ID: 23361457
[TBL] [Abstract][Full Text] [Related]
19. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer.
BorgoƱo CA; Grass L; Soosaipillai A; Yousef GM; Petraki CD; Howarth DH; Fracchioli S; Katsaros D; Diamandis EP
Cancer Res; 2003 Dec; 63(24):9032-41. PubMed ID: 14695222
[TBL] [Abstract][Full Text] [Related]
20. [HE4, a novel marker for epithelial ovarian cancer: evaluation of analytical performances].
Lamy PJ; Roques S; Viglianti C; Fabbro M; Montels F
Ann Biol Clin (Paris); 2010; 68(3):325-9. PubMed ID: 20478777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]